192 related articles for article (PubMed ID: 27871834)
1. pH-Sensitive PEGylated liposomes for delivery of an acidic dinitrobenzamide mustard prodrug: Pathways of internalization, cellular trafficking and cytotoxicity to cancer cells.
Yang MM; Wilson WR; Wu Z
Int J Pharm; 2017 Jan; 516(1-2):323-333. PubMed ID: 27871834
[TBL] [Abstract][Full Text] [Related]
2. Calcium Enabled Remote Loading of a Weak Acid Into pH-sensitive Liposomes and Augmented Cytosolic Delivery to Cancer Cells via the Proton Sponge Effect.
Yang MM; Yarragudi SB; Jamieson SMF; Tang M; Wilson WR; Wu Z
Pharm Res; 2022 Jun; 39(6):1181-1195. PubMed ID: 35229237
[TBL] [Abstract][Full Text] [Related]
3. PEG-Benzaldehyde-Hydrazone-Lipid Based PEG-Sheddable pH-Sensitive Liposomes: Abilities for Endosomal Escape and Long Circulation.
Kanamala M; Palmer BD; Ghandehari H; Wilson WR; Wu Z
Pharm Res; 2018 May; 35(8):154. PubMed ID: 29855807
[TBL] [Abstract][Full Text] [Related]
4. Light induced cytosolic drug delivery from liposomes with gold nanoparticles.
Lajunen T; Viitala L; Kontturi LS; Laaksonen T; Liang H; Vuorimaa-Laukkanen E; Viitala T; Le Guével X; Yliperttula M; Murtomäki L; Urtti A
J Control Release; 2015 Apr; 203():85-98. PubMed ID: 25701610
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a smart pH-cleavable PEG polymer towards the development of dual pH-sensitive liposomes.
Kanamala M; Palmer BD; Wilson WR; Wu Z
Int J Pharm; 2018 Sep; 548(1):288-296. PubMed ID: 29981407
[TBL] [Abstract][Full Text] [Related]
6. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
[TBL] [Abstract][Full Text] [Related]
8. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
[TBL] [Abstract][Full Text] [Related]
9. Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation.
Zhang W; Wang G; See E; Shaw JP; Baguley BC; Liu J; Amirapu S; Wu Z
J Control Release; 2015 Apr; 203():161-9. PubMed ID: 25701612
[TBL] [Abstract][Full Text] [Related]
10. pH-Responsive and liver-targeting drug delivery system for combination delivery of artesunate with arsenic trioxide prodrug against hepatocellular carcinoma.
Pan X; Huang J; Liu S; Shao Y; Xi J; He R; Shi T; Zhuang R; Yu W
Drug Dev Ind Pharm; 2023 Aug; 49(8):485-496. PubMed ID: 37470495
[TBL] [Abstract][Full Text] [Related]
11. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
[TBL] [Abstract][Full Text] [Related]
12. A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: An application for bladder cancer treatment.
Vila-Caballer M; Codolo G; Munari F; Malfanti A; Fassan M; Rugge M; Balasso A; de Bernard M; Salmaso S
J Control Release; 2016 Sep; 238():31-42. PubMed ID: 27444816
[TBL] [Abstract][Full Text] [Related]
13. Plasma stable, pH-sensitive fusogenic polymer-modified liposomes: A promising carrier for mitoxantrone.
Ghanbarzadeh S; Arami S; Pourmoazzen Z; Ghasemian-Yadegari J; Khorrami A
J Biomater Appl; 2014 Jul; 29(1):81-92. PubMed ID: 24336315
[TBL] [Abstract][Full Text] [Related]
14. In vitro characterization of a liposomal formulation of celecoxib containing 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol and its functional effects against colorectal cancer cell lines.
Erdoğ A; Putra Limasale YD; Keskin D; Tezcaner A; Banerjee S
J Pharm Sci; 2013 Oct; 102(10):3666-77. PubMed ID: 23897281
[TBL] [Abstract][Full Text] [Related]
15. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Guo X; Chen D
Int J Pharm; 2015 Mar; 480(1-2):116-27. PubMed ID: 25615984
[TBL] [Abstract][Full Text] [Related]
16. Transfection mechanisms of polyplexes, lipoplexes, and stealth liposomes in α₅β₁ integrin bearing DLD-1 colorectal cancer cells.
Adil MM; Erdman ZS; Kokkoli E
Langmuir; 2014 Apr; 30(13):3802-10. PubMed ID: 24635537
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical characterization of asulacrine towards the development of an anticancer liposomal formulation via active drug loading: stability, solubility, lipophilicity and ionization.
See E; Zhang W; Liu J; Svirskis D; Baguley BC; Shaw JP; Wang G; Wu Z
Int J Pharm; 2014 Oct; 473(1-2):528-35. PubMed ID: 25079434
[TBL] [Abstract][Full Text] [Related]
18. Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: benefits over classical vesicles.
Ducat E; Deprez J; Gillet A; Noël A; Evrard B; Peulen O; Piel G
Int J Pharm; 2011 Nov; 420(2):319-32. PubMed ID: 21889584
[TBL] [Abstract][Full Text] [Related]
19. Liposomes as Delivery System of a Sn(IV) Complex for Cancer Therapy.
Corvo ML; Mendo AS; Figueiredo S; Gaspar R; Larguinho M; Guedes da Silva MF; Baptista PV; Fernandes AR
Pharm Res; 2016 Jun; 33(6):1351-8. PubMed ID: 27033349
[TBL] [Abstract][Full Text] [Related]
20. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB
Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
